Is California Regulating the Barrel to Eliminate the Spoiled Apple?

Does one rotten apple actually spoil the whole barrel?  According to science, the answer is yes and according to the California legislature, the answer also appears to be yes, at least when it comes to pharmaceutical donations.  Largely in response to the high-profile Giving Children Hope scandal (where a charitable organization, via subsidiaries, purchased $225,000 in pharmaceuticals from a Netherlands wholesaler and then recorded those purchases as a $34.9 million pharmaceutical donation), the California legislature passed Assembly Bill 1181 in September of 2019.  And while the bill was vetoed by California Governor Gavin Newsome in mid-October, the bill passed by overwhelming bipartisan support, setting up a potential veto override later this year.

AB 1181 seeks to require any charitable organization soliciting donations in California to value drug and medical supply donations based upon the fair market value of where the drugs will ultimately be utilized.  Currently, under U.S. GAAP, a non-cash contribution, also known as a gift-in-kind, is required to be recognized at fair value.  The problem, however, is that while many donated pharmaceuticals are utilized for international purposes, most pharmaceuticals are valued based on U.S. fair market value.  It should come as no surprise that drug prices in the U.S. tend to be significantly higher than in the rest of the world, and are especially higher than where most of the drugs and supplies get utilized. 

Proponents of AB 1181 believe that this discrepancy leads to an over-valuation of pharmaceuticals, and allows certain bad actors to “pad” administrative costs, offer higher executive salaries, and mislead the donating public about charitable efficiency.  Proponents of the bill are lauding California for attempting to correct what both the Federal government and many states have long viewed as a loophole in US GAAP, leading to abuse and misrepresentation. 

Opponents, however, argue that valuing donations based on county of distribution becomes an administrative nightmare, which will lead to higher accounting costs, divert funds away from programming, and could require separate records for GAAP and California compliance.  Opponents argue that the rules of AB 1181 are difficult to implement and that additional guidance is needed.  Finally, opponents wonder if the regulation goes too far in trying to correct one-off bad actors by regulating all charities that take contributions from California sources.

While AB 1181 is a California bill, it has the potential to impact any organization soliciting donations, nationwide.  Generally speaking, once a charity obtains donations from California donors, it becomes subject to AB 1181 and will need to comply on all pharmaceutical donations. 

For now, though, charitable organizations have gotten a bit of a reprieve thanks to the Governor’s veto, but should remain vigilant to the extent the bill comes around again.  We will continue to monitor the progress of AB 1181, but in the meantime, if you have any questions or are seeking additional information related to AB 1181, please feel free to contact us at Schneider Downs and we will be more than happy to assist!

You’ve heard our thoughts… We’d like to hear yours

The Schneider Downs Our Thoughts On blog exists to create a dialogue on issues that are important to organizations and individuals. While we enjoy sharing our ideas and insights, we’re especially interested in what you may have to say. If you have a question or a comment about this article – or any article from the Our Thoughts On blog – we hope you’ll share it with us. After all, a dialogue is an exchange of ideas, and we’d like to hear from you. Email us at contactSD@schneiderdowns.com.

Material discussed is meant for informational purposes only, and it is not to be construed as investment, tax, or legal advice. Please note that individual situations can vary. Therefore, this information should be relied upon when coordinated with individual professional advice.

© 2020 Schneider Downs. All rights-reserved. All content on this site is property of Schneider Downs unless otherwise noted and should not be used without written permission.

our thoughts on

Final 163(j) Regulations a Win for Manufacturers and Private Equity-Owned Businesses
Choosing The Wrong Accounting Method for Home Construction Contracts is a Costly Mistake
2020-2021 Special Per Diem Rates
Notices for Nonpayment of Income Taxes
Pennsylvania Commonwealth Court Decides Market-Based Sourcing for Services Prior to Legislative Change in 2014
IRS Extends 2020 Rollover Period and Other Deadlines for Retirement Account RMDs

Register to receive our weekly newsletter with our most recent columns and insights.

Have a question? Ask us!

We’d love to hear from you. Drop us a note, and we’ll respond to you as quickly as possible.

Ask us

contact us

Map of Pittsburgh Office
Pittsburgh

One PPG Place, Suite 1700
Pittsburgh, PA 15222

contactsd@schneiderdowns.com
p:412.261.3644     f:412.261.4876

Map of Columbus Office
Columbus

65 East State Street, Suite 2000
Columbus, OH 43215

contactsd@schneiderdowns.com
p:614.621.4060     f:614.621.4062

Map of Washington Office
Washington, D.C.

1660 International Drive, Suite 600
McLean, VA 22102